We identified 24 APS patients, the majority of whom (83.3%) already had elevated aPL levels at the time of DVT, including aCL, anti-β2GPI, and aPS/PT, which remained positive throughout follow-up. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.